Study of the parameters influencing the co-grinding process for the production of meloxicam nanoparticles

Powder Technology

Volumn 212, Issue 1, 2011, Pages 210-217

  Kürti, Levente ^a,b   Kukovecz, Ákos ^a   Kozma, Gábor ^a   Ambrus, Rita ^a   Deli, Mária A ^a   Szabó Révész, Piroska ^a  

^a UNIVERSITY OF SZEGED   (Hungary)

^b INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

Author keywords

Co grinding; Factorial experimental design; Meloxicam; Nanoparticle; Nasal powder system; Scanning electron microscopy

Indexed keywords

CO-GRINDING; FACTORIAL EXPERIMENTAL DESIGN; MELOXICAM; NASAL POWDER SYSTEM; SCANNING ELECTRONS;

CRYSTALLINE MATERIALS; DISSOLUTION; DRUG DELIVERY; GLYCOLS; GRINDING (MACHINING); NANOPARTICLES; OPTIMIZATION; POLYETHYLENE GLYCOLS; ROTATION; SCANNING ELECTRON MICROSCOPY; X RAY POWDER DIFFRACTION;

GRINDING (COMMINUTION);

MACROGOL; MELOXICAM; NANOPARTICLE; POVIDONE;

ARTICLE; CHEMICAL COMPOSITION; CONTROLLED STUDY; DRUG DETERMINATION; ENERGY YIELD; FACTORIAL DESIGN; FLOW KINETICS; GRINDING; MATERIAL STATE; NANOANALYSIS; NANOFABRICATION; PARTICLE SIZE; PROCESS OPTIMIZATION; REDUCTION KINETICS; SCANNING ELECTRON MICROSCOPY; SURFACE PROPERTY; X RAY DIFFRACTION;

EID: 79959942228     PISSN: 00325910     EISSN: 1873328X     Source Type: Journal    
DOI: 10.1016/j.powtec.2011.05.018     Document Type: Article

References (51)

1. Alonso M.J. Nanomedicines for overcoming biological barriers. Biomed. Pharmacother. 2004, 58:168-172.
2. Graf A., Ablinger E., Peters S., Zimmer A., Hook S., Rades T. Microemulsions containing lecithin and sugar-based surfactants: nanoparticle templates for delivery of proteins and peptides. Int. J. Pharm. 2008, 350:351-360.
3. De Jong W.H., Borm P.J.A. Drug delivery and nanoparticles: applications and hazards. Int. J. Nanomed. 2008, 3/2:133-149.
4. Chen H., Khemtong C., Yang X., Chang X., Gao J. Nanonization strategies for poorly water-soluble drugs. Drug Discov. Today 2010, 10.1016/j.drudis.2010.02.009.
5. Brooking J., Davis S.S., Illum L. Transport of nanoparticles across the rat nasal mucosa. J. Drug Target 2001, 9:267-279.
6. Rawat M., Singh D., Saraf S. Nanocarriers: promising vehicle for bioactive drugs. Biol. Pharm. Bull. 2006, 29/9:1790-1798.
7. Shegokar R., Müller R.H. Nanocrystals: industrially feasible multifunctional formulation technology for poorly soluble actives. Int. J. Pharm. 2010, 399:129-139.
8. Keck C.M., Müller R.H. Drug nanoparticles of poorly soluble drugs produced by high pressure homogenisation. Eur. J. Pharm. Biopharm. 2006, 62:3-16.
9. Vegt O.d., Vromans H., Toonder J.d., Maarschalk K.v.d.V. Influence of flaws and crystal properties on particle fracture in a jet mill. Powder Technol. 2009, 191:72-77.
10. Delagrammatikas G., Delagrammatikas M., Tsimas S. Particle size distributions a new approach. Powder Technol. 2007, 176:57-65.
11. Kubo H., Osawa T., Takashima K., Mizobe M. Enhancement of oral bioavailability and pharmacological effect of by micronization in co-ground mixture with d-mannitol. Biol. Pharm. Bull. 1997, 19:741-747.
12. Liversidge G.G., Cundy K.C. Particle size reduction for improvement of oral bioavailability of hydrophobic drugs: absolute oral bioavailability of nanocrystalline danazol in beagle dogs. Int. J. Pharm. 1995, 125:91-97.
13. Sugimoto M., Okagaki T.S., Narisawa S., Koida Y., Nakajima K. Improvement of dissolution characteristics and bioavailability of poorly water-soluble drugs by novel cogrinding method using water-soluble polymer. Int. J. Pharm. 1998, 160:11-19.
14. Yamada T., Saito N., Imai T., Otagiri M. Effect of grinding with hydroxypropyl cellulose on the dissolution and particle size of a poorly water-soluble drug. Chem. Pharm. Bull. 1999, 47:1311-1313.
15. G:G. Liversidge, K.C. Cundy, J. Bishop, D. Czekai, Surface modified drug nanoparticles, US Patent (1992) 5,145,684.
16. Rabinow B.E. Nanosuspensions in drug delivery. Nat. Rev. Drug Discov. 2004, 3:785-796.
17. Moribe K., Pongpeerapat A., Tozuka Y., Yamamoto K. Drug nanoparticle formation from drug/HPMC/SDS ternary ground mixtures. Pharmazie 2006, 61:97-101.
18. Zapata C., Frances C., Le Bolay N., Molina-Boisseau S. Production of small composite particles by co-grinding in a media mill. Characterization of the granulometric and the mechanical properties. Trans. IChemE, Part A, Ch. E. R. D. 2004, 82(A5):631-636.
19. Barzegar-Jalali M., Valizadeh H., Siahi Shadbad M.-R., Adibkia K., Mohammadi G., Farahani A., Arash Z., Nokhodchi A. Cogrinding as an approach to enhance dissolution rate of a poorly water-soluble drug (gliclazide). Powder Technol. 2010, 197:150-158.
20. Kukovecz Á., Méhn D., Nemes-Nagy E., Szabó R., Kiricsi I. Optimization of CCVD synthesis conditions for single-wall carbon nanotubes by statistical design of experiments (DoE). Carbon 2005, 43:2842-2849.
21. Hennart S.L.A., Domingues M.C., Wildeboer W.J., van Hee P., Meesters G.M.H. Study of the process of stirred ball milling of poorly water soluble organic products using factorial design. Powder Technol. 2010, 198:56-60.
22. Fahmy M. Ca-alginate beads loaded with meloxicam: effect of alginate chemical composition on the properties of the beads and ulcerogenicity of the drug. J. Drug Del. Sci. Technol. 2006, 16:183-189.
23. Hanft G., Turck D., Scheuerer S., Sigmund R. Meloxicam oral suspension: a treatment alternative to solid meloxicam formulations. Inflamm. Res. 2001, 50:35-37.
24. Ambrus R., Kocbek P., Kristl J., Sibanc R., Rajkó R., Szabó-Révész P. Investigation of preparation parameters to improve the dissolution of poorly water-soluble meloxicam. Int. J. Pharm. 2009, 381:153-159.
25. Jafar M., Dehgan M.H.G., Shareef A. Enhancement of dissolution and antiinfammatory effect of meloxicam using solid dispersions. Int. J. App. Pharm. 2010, 2/1:22-27.
26. Shakhtshneider T.P., Vasiltchenko M.A., Politov A.A., Boldyrev V.V. The mechanochemical preparation of solid disperse systems of ibuprofen-polyethylene glycol. Int. J. Pharm. 1996, 130:25-32.
27. Ioth K., Pongpeerapat A., Tozuka Y., Oguchi T., Yamamoto K. Nanoparticle formation of poorly water-soluble drugs from ternary ground mixtures with PVP and SDS. Chem. Pharm. Bull. 2003, 51(2):171-174.
28. Taylor L.S., Zografi G. Spectroscopic characterization of interactions between PVP and indomethacin in amorphous molecular dispersion. Pharm. Res. 1997, 14:1691-1698.
29. Watanabe T., Hasegawa S., Wakiyama N., Kusai A., Senna M. Comparison between polyvinylpyrrolidone and silica nanoparticles as carriers for indomethacin in a solid state dispersion. Int. J. Pharm. 2003, 250:283-286.
30. Smajda R., Kukovecz Á., Kónya Z., Kiricsi I. Structure and gas permeability of multi-wall carbon nanotube buckypapers. Carbon 2007, 45/6:1176-1184.
31. Daranyi M., Kukovecz Á., Horváth E., Kónya Z., Kiricsi I. Fine tuning the coverage of a titanate nanowire layer on a glass substrate. Chem. Phys. Lett. 2008, 460(1-3):191-195.
32. Melero J.A., Calleja G., Martinez F., Molina R., Pariente M.I. Nanocomposite Fe2O3/SBA-15: an efficient and stable catalyst for the catalytic wet peroxidation of phenolic aqueous solutions. Chem. Eng. J. 2007, 131(1-3):245-256.
33. Abramoff M.D., Magelhaes P.J., Ram S.J. Image processing with image. J. Biophotonics Int. 2004, 11/7:36-42.
34. Remias R., Kukovecz Á., Daranyi M., Kozma G., Varga S., Kónya Z., Kiricsi I. Zn-glycerolate microstacks. Eur. J. Inorg. Chem. 2009, 24:3622-3627.
35. Zapata-Massot C., Frances C., Le Bolay N. On the use of scanning electron microscopy for the modelling of co-grinding kinetics in a tumbling ball mill. Powder Technol. 2004, 143-144:215-229.
36. Alkebro J., BeHgin-Colin S., Mocellin A., Warren R. Modeling high-energy ball milling in the alumina-yttria system. J. Solid State Chem. 2002, 164:88-97.
37. Chattopadhyay P.P., Manna I., Talapatra S., Pabi S.K. A mathematical analysis of milling mechanics in a planetary ball mill. Mater. Chem. Phys. 2001, 68:85-94.
38. Muller R.H., Akkar A. Drug nanocrystals of poorly soluble drugs. Encyclopedia of Nanoscience and Nanotechnology 2004, 627-638. Marcel Dekker, New York. J.A. Schwarz, C. Contescu, K. Putyera (Eds.).
39. Patravale V.B., Date A.A., Kulkarni R.M. Nanosuspensions: a promising drug delivery strategy. J. Pharm. Pharmacol. 2004, 56:827-840.
40. Mosharraf M., Nystrom C. The effect of particle size and shape on the surface specific dissolution rate of micronized practically insoluble drugs. Int. J. Pharm. 1995, 122:35-47.
41. Kesisoglou F., Panmai S., Wu Y. Nanosizing - oral formulation development and biopharmaceutical evaluation. Adv. Drug Deliv. Rev. 2007, 5916:31-44.
42. Noyes A.A., Whitney W.R. The rate of solution of solid substances in their own solutions. J. Am. Chem. Soc. 1897, 19:930-934.
43. Senna M., Nakayama S. Preparation and properties of nano-amorphous organic and inorganic particles via chemical and mechanochemical routes. J. Alloys Compd. 2009, 483:265-270.
44. Dhumal R.S., Biradar S.V., Yamamura S., Paradkar A.R., York P. Preparation of amorphous cefuroxime axetil nanoparticles by sonoprecipitation for enhancement of bioavailability. Eur. J. Pharm. Biopharm. 2008, 70:109-115.
45. Crisp M.T., Tucker C.J., Rogers T.L., Williams R.O., Johnston K.P. Turbidimetric measurement and prediction of dissolution rates of poorly soluble drug nanocrystals. J. Control. Release 2007, 117:351-359.
46. Ishikawa F., Murano M., Hiraishi M., Yamaguchi T., Tamai I., Tsuji A. Insoluble powder formulation as an effective nasal drug delivery system. Pharm. Res. 2002, 19. No. 8.
47. Fransén N., Bredenberg S., Björk E. Clinical study shows improved absorption of desmopressin with novel formulation. Pharm. Res. 2009, 26:1618-1625.
48. Fransén N., Björk E., Nyström C. Development and characterisation of interactive mixtures with a fine-particulate mucoadhesive carrier for nasal drug delivery. Eur. J. Pharm. Biopharm. 2007, 67:370-376.
49. Ishikawa F., Katsura M., Tamai I., Tsuji A. Improved nasal bioavailability of elcatonin by insoluble powder formulation. Int. J. Pharm. 2001, 224:105-114.
50. Lee W.A., Narog B.A., Patapoff T.W., Wang Y.J. Intranasal bioavailability of insulin powder formulations: effect of enhancer-to-protein ratio. J. Pharm. Sci. 1991, 80:72-729.
51. Schipper N.G.M., Romejin S.G., Verhoef J.C., Merkus F.W.H.M. Nasal insulin delivery with dimethyl-β-cyclodextrin as an absorption enhancer in rabbits: powder more effective than liquid formulations. Pharm. Res. 1993, 10:682-686.